Form CT ORDER Logicbio Therapeutics, Inc.

Confidential treatment order

Filed: 2018-10-18 16:08:51
Dated: 2018-10-18
filename1.pdf


                             UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION
                              October 18, 2018

              ORDER GRANTING CONFIDENTIAL TREATMENT
                  UNDER THE SECURITIES ACT OF 1933

                             LogicBio Therapeutics, Inc.

                           File No. 333-227523 - CF#36672
                               _____________________

        LogicBio Therapeutics, Inc. submitted an application under Rule 406 requesting
confidential treatment for information it excluded from the Exhibits to a Form S-1
registration statement filed on September 25, 2018, as amended.

        Based on representations by LogicBio Therapeutics, Inc. that this information
qualifies as confidential commercial or financial information under the Freedom of
Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined
not to publicly disclose it. Accordingly, excluded information from the following
exhibits will not be released to the public for the time periods specified:

                      Exhibit 10.1          through August 13, 2021
                      Exhibit 10.2          through August 13, 2021


       For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:



                                            Brent J. Fields
                                            Secretary



Document Created: 2018-10-18 16:07:25
Document Modified: 2018-10-18 16:07:25
Additional Files
FileSequenceDescriptionTypeSize
9999999997-18-008680.txt   Complete submission text file   108429

© 2019 SEC.report
This site is not affiliated with or endorsed by the SEC.
The SEC operates under the authority of Title 17 of the Code of Federal Regulations.